Keywords: نوش; ApoA-I; apolipoprotein A1; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; CHE; cholinesterase; CT; computerized tomography; CVD; cardiovascular diseases; FLI; fatty liver index; FFA; free f
مقالات ISI نوش (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نوش; Diet; Metabolic syndrome; Non alcoholic; NAFLD; NASH; Steatosis;
Keywords: نوش; Lipocalin 2; Fat; MCD; NASH; PIP3; Oxidative stress; Mitochondria;
Keywords: نوش; ED; Emergency Department; ICP; Integrated Care Pathway; NASH; National Audit of Seizure management in Hospitals; AAN; American Academy of Neurology; NICE; National Institute for Health and Care Excellence; Barriers to evidence based care; Care pathway; Em
Keywords: نوش; TACE; Transarterial Chemoembolization; cTACE; conventional Transarterial Chemoembolization; HCC; hepatocellular carcinoma; EASL; European Association for the Study of the Liver Guidelines; qEASL; 3D quantitative European Association for the Study of the L
Keywords: نوش; ALA; α-lipoic acid; AMPK; AMP-activated protein kinase; eNOS; endothelial NO synthase; ECM; extracellular matrix; ET-1; endothelin-1; EVs; extracellular vesicles; HCS; Hepatic stellate cells; HI; intermittent hypoxia; NO; nitric oxide; NAFLD; nonalcoholi
Keywords: نوش; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; birth weight; obesity; children; epidemiology; BMI; Body mass index; HBW; High birth weight; LBW; Low birth weight; NAFLD; Nonalcoholic fatty liver disease; NASH; Nonalcoholic steatohepatitis
Keywords: نوش; GRP78; glucose regulated protein 78; NASH; nonalcoholic steatohepatitis; ERS; endoplasmic reticulum stress; IETM; intestinal endotoxemia; ALT; alanine transferase; TG; triglyceride; FFA; free fatty acid; TNFα; tumor necrosis Factor-α; MDA; malondialdehy
Keywords: نوش; ABCA1; ATP-binding cassette sub-family A member 1; AMPK; adenosin monophosphate-activated protein kinase; EGCG; epigallocatechin gallate; GPx; glutathione peroxidase; GSH; glutathione; HDL; high density lipoproteins; HMGCoA-r; hydroxy-methyl glutaryl-coen
Keywords: نوش; ANIT; alpha-naphthyl isothiocyanate; APAP; acetaminophen; ASC; activated stellate cells; ASH; alcoholic steatohepatitis; BDL; Bile duct ligation; BW; body weight; CC; cholangiocytes; CCl4; carbon tetrachloride; CDE; choline-deficient ethionine-supplemente
Keywords: نوش; APCs; antigen-presenting cells; DAMPs; danger-associated molecular patterns; DCs; Donor-derived dendritic cells; ET; endotoxin tolerance; FFA; free fatty acids; Gsdmd; gasdermin D; HDAC11; Histone deacetylase 11; HFD; high fat diet; HMGB1; high mobility g
Supplementation with Lycium chinense fruit extract attenuates methionine choline-deficient diet-induced steatohepatitis in mice
Keywords: نوش; NAFLD; non-alcoholic fatty liver disease; TG; triacylglycerol; NASH; non-alcoholic steatohepatitis; ROS; reactive oxygen species; NF-κB; nuclear factor-κB; JNK; c-jun N-terminal kinase; LFE; Lycium chinense fruit extract; MCD diet; methionine-choline-de
Keywords: نوش; NAFLD; nonalcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; MHNO; metabolically healthy non-obese; MUNO; metabolically unhealthy non-obese; MHO; metabolically healthy obese; MUO; metabolically unhealthy obese; DM; diabetes mellitus; TE;
Keywords: نوش; Hepatocellular carcinoma; Type II diabetes mellitus; Insulin; Sorafenib; Metformin; SIRT-3; NASH; NAFLD; Liver cancer;
Keywords: نوش; genome wide; Hispanic; fatty liver; fibrosis; pediatrics; BMI; Body mass index; CRN; Clinical Research Network; GWAS; Genome-wide association study; NAFLD; Nonalcoholic fatty liver disease; NAS; Nonalcoholic fatty liver disease activity score; NASH; Nonal
Keywords: نوش; NASH; nonalcoholic steatohepatitis; NAFD; nonalcoholic fatty liver disease; FXR; farnesoid X receptor; FGF19; fibroblast growth factor; DMSO; dimethyl sulfoxide; CYP; cytochrome P450; Liver; Flow; FXR; NASH; Transcriptomics; Obeticholic;
Comparison of chemical structures and cytoprotection abilities between direct and indirect antioxidants
Keywords: نوش; AAPH; 2,2â²-azobis (2-amidinopropane) dihydrochloride; ARE; antioxidant responsive element; CAT; catalase; DHMBA; 3,5-dihydroxy-4-methoxybenzyl alcohol; DPPH; 2,2-diphenyl-1-picryl-hydrazyl; FBS; fetal bovine serum; GAPDH; glyceraldehyde-3-phosphate dehy
Keywords: نوش; CTL; cytotoxic T cells; HCC; hepatocellular carcinomas; HSC; hepatic stellate cells; LSEC; liver sinusoidal endothelial cells; MDSC; myeloid-derived suppressor cells; NASH; non-alcoholic steatohepatitis; NK cells; Natural Killer cells; TAM; tumor-associat
Keywords: نوش; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; CD; control diet; HFD; high fat diet; LHD; lard-rich high calorie diet; MHD; menhaden oil-containing high-calorie diet; SOD; superoxide dismutase; ROS; reactive oxygen species;
Keywords: نوش; SC; Silibinin Capsules; HFD; High fat diet; NAFLD; nonalcoholic fatty liver disease; TG; triglyceride; FA; fatty acid; AMPK; adenosine monophosphate activated protein kinase; NASH; nonalcoholic steatohepatitis; PPARγ; peroxisome proliferator-activated re
Keywords: نوش; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; GLP-1RAs; glucagon-like peptide-1 receptor agonists; RCT; randomized controlled trial; MD; mean difference; CI; confidence interval; OR; odds ratio; T2D; type 2 diabetes; GGT;
Keywords: نوش; Macrophage; Monocyte; Kupffer cell; Liver fibrosis; NASH; Chemokine; HCC; Cholestasis; HBV; HCV;
Keywords: نوش; Steatohepatitis; NASH; Obesity; Metabolic syndrome; Histopathology;
Keywords: نوش; ATF6; activating transcription factor 6; CHOP; C/EBP-homologous protein; CVD; cardiovascular disease; eIF2α; eukaryotic translation initiator factor 2α; ER; endoplasmic reticulum; GRP78; glucose regulated protein 78; IDL; intermediate-density lipoprotei
Keywords: نوش; NAFLD; NASH; Treatment; Clinical trials; Nonantifibrotics;
Keywords: نوش; Obesity; Liver transplantation; Bariatric surgery; Cirrhosis; NASH;
Keywords: نوش; Aging; Age-related disease; Lipid metabolism; NAFLD; NASH;
Keywords: نوش; 5-HT(2B); 5-hydroxytryptamine 2B receptor; ACE; angiotensin-converting enzyme; AMPK; AMP-activated protein kinase; ARB; AT1R blocker; ASK1; apoptosis signal-regulating kinase 1; AT1R; angiotensin II type 1 receptor; ATX; autotaxin; BDL; bile duct ligation
Keywords: نوش; Liver Cancer; HCC; Tumor Metabolism; EMT; epithelial to mesenchymal transition; FA; fatty acid; HCC; hepatocellular carcinoma; logFC; log of fold change; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; NB; nucleotide biosynthe
Keywords: نوش; Liver biopsy; Bariatric surgery; NASH; Risk;
Keywords: نوش; UNOS/OPTN; Database; Liver Cancer; LT; BMI; body mass index; CI; confidence interval; DAA; direct antiviral agent; HCC; hepatocellular carcinoma; HBV; hepatitis B virus; HCV; hepatitis C virus; HR; hazard ratio; LT; liver transplantation; MELD; Model for
Keywords: نوش; Elderly donors; Extended criteria donors; Marginal donors; Liver transplantation; MELD; Model of end stage liver disease; ROS; Oxygen free radicals; ER; Endoplasmic reticulum; DAMP's; Danger associated molecular pattern's; KC's; Kupffer cells; TLR-4; Roll
Keywords: نوش; NAFLD; nonalcoholic fatty liver disease; ALD; alcoholic liver disease; TLRs; Toll-like receptors; NLRs; Nod-like receptors; NASH; nonalcoholic steatohepatitis; BT; bacterial translocation; HE; hepatic encephalopathy; ACLF; acute on chronic liver failure;
Keywords: نوش; Non-alcoholic steatohepatitis; Endoplasmic reticulum stress activated indicator-luciferase mice; Endoplasmic reticulum stress; In vivo imaging; ER; Endoplasmic reticulum; NASH; Non-alcoholic steatohepatitis; mCDAA; modified choline-deficient l-amino acid
Keywords: نوش; Body Weight; Waist Size; Risk Factor; Disease Progression; ALT; alanine aminotransferase; BMI; body mass index; CI; confidence interval; cIMT; carotid intima-media thickness; cplaques; carotid plaques; MetS; metabolic syndrome; NAFLD; nonalcoholic fatty l
Keywords: نوش; Non-alcoholic fatty liver disease; NAFLD; Metabolic disease; Hedgehog; SHH; GLI2; NASH; Liver fibrosis; Cirrhosis; Hepatocellular carcinoma; Holoprosencephaly; HPE;
Keywords: نوش; CARDIA Study; NASH; Heart Disease; NAFLD; A; late (atrial) transmitral velocity; BMI; body mass index; CAC; coronary artery calcification; CARDIA; Coronary Artery Risk Development in Young Adults study; CI; confidence interval; CT; computed tomography; CV
Keywords: نوش; ALT; alanine aminotransferase; ChREBP; carbohydrate response element binding protein; CXCL10; CXC motif chemokine ligand 10; DGAT2; diglyceride acyltransferase 2; DNL; de novo lipogenesis; FAME; fatty acid methyl ester; FAS; fatty acid synthase; GAPDH; gl
Keywords: نوش; Mouse Model; Lipid Metabolism; 1-Carbon Metabolism; Prognostic; ALT; alanine aminotransferase; DG; diglycerides; DMR; differentially methylated DNA regions; FA; fatty acids; GSH; glutathione; JC-1; 5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolyl-carb
Keywords: نوش; aKG; alfa keto glutarate; Akt/PKB; serine/threonine-specific protein kinase B; AMPK; 5â² adenosine monophosphate-activated protein kinase; ASPEN; American Society of Parenteral and Enteral Nutrition; ATP; adenosine triphosphate; BIA; bio-electric impedan
Keywords: نوش; ATP; adenosine triphosphate; Ca2+; Â calcium; CamK; calmodulin-dependent kinase; ChREBP; carbohydrate response element binding protein; CypD; cylophilin D; DGAT2; diacylglycerol acyltransferase 2; ER; endoplasmic reticulum; FOXO1; Forkhead box O1; G6P; gl
Keywords: نوش; FLINT; NAFLD; Direct Comparison; Non-Invasive; AUROC; area under receiving operating curve; CI; confidence interval; CRN; clinical research network; EOT; end of treatment; MRI; magnetic resonance imaging; NAFLD; nonalcoholic fatty liver disease; NASH; non
Keywords: نوش; Liver; Pancreas; Gallbladder; Cancer; Fat; BMI; body mass index; CI; confidence interval; GERD; gastroesophageal reflux disease; HCC; hepatocellular carcinoma; LES; lower esophageal sphincter; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic st
Keywords: نوش; ACC; acetyl-CoA carboxylase; ApoB; apolipoprotein B; ApoCII; apolipoprotein C-II; APPL-1; adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and a leucine zipper motif; CD36; fatty acid translocase; CETP; cholesteryl est
Keywords: نوش; Bile Acids; FXR; TGR5; Meta-Inflammation; apo; apolipoprotein; ASBT; apical sodiumâdependent bile acid transporter; BA; bile acid; BAS; bile acid sequestrant; BAT; brown adipose tissue; BSH; bile salt hydrolase; CA; cholic acid; CCK; cholecystokinin; CD
Keywords: نوش; ACSL; Acyl-CoA synthetases; ANOVA; analysis of variance; CHP; cumene hydroperoxide; CPT1; carnitine palmitoyltransferase 1; CRAT; carnitine acetyltransferase; DHB; 2,5-dihydroxybenzoic acid; FABP; fatty acid binding protein; FCCP; carbonyl cyanide-4-(trif
Keywords: نوش; LPS; lipopolysaccharide; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; TGF; transforming growth factor; TLR; toll like receptor; TNF; tumor necrosis factor;
Keywords: نوش; AR; androgen receptor; ER; estrogen receptor; HCC; hepatocellular carcinoma; MELD; Model for End-Stage Liver Disease; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; OS; overall survival;
Keywords: نوش; ALT; alanine aminotransferase; APRI; aspartate aminotransferase (AST)-to-platelet ratio index; AST; aspartate aminotransferase; BMI; body mass index; DM; diabetes mellitus; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; NAS
Keywords: نوش; T2DM; type 2 diabetes; CLD; chronic liver disease; ALD; alcoholic liver disease; NAFLD; non-alcoholic fatty liver disease; SES; socio-economic status; RR; rate ratio; HCC; hepatocellular carcinoma; NASH; non-alcoholic steatohepatitis; SIMD; Scottish index